We are live on ! Find out more
OCGN icon

Ocugen

96 hedge funds and large institutions have $26.5M invested in Ocugen in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 10 increasing their positions, 30 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $387K | Put options by funds: $200K

7% less funds holding

Funds holding: 10396 (-7)

8.55% less ownership

Funds ownership: 27.55%19% (-8.5%)

17% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 36

50% less capital invested

Capital invested by funds: $53.2M → $26.5M (-$26.8M)

67% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 30

Holders
96
Holders Change
-7
Holders Change %
-6.8%
% of All Funds
1.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
10
Reduced
30
Closed
36
Calls
$387K
Puts
$200K
Net Calls
+$187K
Net Calls Change
-$33K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.41M -$775K -1,208,505 -9%
LM
2
Luminus Management
Texas
$2.22M +$2.62M +4,079,238 New
GC
3
GMT Capital
Georgia
$2.13M +$2.51M +3,922,198 New
BlackRock
4
BlackRock
New York
$2.12M -$7.18M -11,204,506 -74%
JP Morgan Chase
5
JP Morgan Chase
New York
$1.65M -$65.1K -101,501 -3%
Millennium Management
6
Millennium Management
New York
$1.64M +$1.12M +1,748,855 +138%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.55M -$1.15M -1,798,365 -39%
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$1.36M +$1.6M +2,500,000 New
Renaissance Technologies
9
Renaissance Technologies
New York
$1.34M +$122K +189,608 +8%
Charles Schwab
10
Charles Schwab
California
$616K -$247K -384,808 -25%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$593K +$700K +1,092,269 New
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$587K +$693K +1,081,149 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$569K -$881K -1,373,928 -57%
State Street
14
State Street
Massachusetts
$479K -$3.36M -5,232,485 -86%
Citadel Advisors
15
Citadel Advisors
Florida
$311K +$179K +279,457 +95%
Jane Street
16
Jane Street
New York
$253K +$21.8K +33,988 +8%
Verition Fund Management
17
Verition Fund Management
Connecticut
$217K +$256K +400,000 New
Northern Trust
18
Northern Trust
Illinois
$212K -$913K -1,423,292 -78%
Bank of America
19
Bank of America
North Carolina
$202K -$75.9K -118,388 -24%
CSS
20
Cubist Systematic Strategies
Connecticut
$195K +$115K +179,242 +100%
Morgan Stanley
21
Morgan Stanley
New York
$190K -$30.9K -48,166 -12%
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$179K +$212K +330,062 New
HF
23
HRT Financial
New York
$136K -$485K -756,532 -75%
VF
24
Virtu Financial
New York
$120K +$142K +220,686 New
PMEF
25
Point72 Middle East FZE
United Arab Emirates
$114K +$135K +210,342 New

OCGN Hedge Fund Activity: Q2 2023 in Review

96 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q2 2023, worth a combined $26.5M — down 50% from $53.2M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of OCGN and 30 opened new positions — a net loss of 6 holders — while 30 trimmed existing stakes and 10 added.

The largest buyer was Luminus Management, opening a new position worth an estimated $2.62M. The largest seller was BlackRock, cutting an estimated $7.18M.

  • 96 institutional investors held Ocugen (OCGN) as of Q2 2023, down from 103 in Q1 2023.
  • Funds reported $26.5M of Ocugen stock for Q2 2023, down 50% quarter-over-quarter.
  • 30 funds opened new Ocugen positions in Q2 2023 and 36 closed out, a net change of -6 holders.
  • The largest Ocugen buyer in Q2 2023 was Luminus Management, an estimated $2.62M added.
  • The largest Ocugen seller in Q2 2023 was BlackRock, an estimated $7.18M sold.

Based on aggregated 13F filings for Q2 2023.